Abstract
Docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,16,19) is the longest chain and most unsaturated fatty acid commonly found in biological systems [1]. It represents the extreme example of the important class of fatty acids known as omega-3s. Primarily through dietary studies, this fatty acid has been linked to an enormous variety of human afflictions including cancer [2, 3], heart disease [4], rheumatoid arthritis [5], lupus [6], alcoholism [7], blindness [8], respiratory diseases [9], peroxisomal disorders [10], cystic fibrosis [11], schizophrenia [12], depression [13], malaria [14], multiple sclerosis [15] and even migrane headaches. In order for one simple molecule to affect so many seemingly unrelated processes it must function at a fundamental level, common to most cells. It has been suggested that this level is in controlling membrane structure and function [16]. Due to its extreme chain length and unsaturation it should be easier to demonstrate a unique role for DHA in membrane structure/function than it will be for other shorter, less unsaturated fatty acids commonly found in membranes. Reviewed here is the possible involvement of DHA in membrane lipid domains.
Current Organic Chemistry
Title: Docosahexaenoic Acid and Membrane Lipid Domains
Volume: 4 Issue: 11
Author(s): William Stillwell
Affiliation:
Abstract: Docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,16,19) is the longest chain and most unsaturated fatty acid commonly found in biological systems [1]. It represents the extreme example of the important class of fatty acids known as omega-3s. Primarily through dietary studies, this fatty acid has been linked to an enormous variety of human afflictions including cancer [2, 3], heart disease [4], rheumatoid arthritis [5], lupus [6], alcoholism [7], blindness [8], respiratory diseases [9], peroxisomal disorders [10], cystic fibrosis [11], schizophrenia [12], depression [13], malaria [14], multiple sclerosis [15] and even migrane headaches. In order for one simple molecule to affect so many seemingly unrelated processes it must function at a fundamental level, common to most cells. It has been suggested that this level is in controlling membrane structure and function [16]. Due to its extreme chain length and unsaturation it should be easier to demonstrate a unique role for DHA in membrane structure/function than it will be for other shorter, less unsaturated fatty acids commonly found in membranes. Reviewed here is the possible involvement of DHA in membrane lipid domains.
Export Options
About this article
Cite this article as:
Stillwell William, Docosahexaenoic Acid and Membrane Lipid Domains, Current Organic Chemistry 2000; 4 (11) . https://dx.doi.org/10.2174/1385272003375860
DOI https://dx.doi.org/10.2174/1385272003375860 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation
Medicinal Chemistry Role of Endothelial Progenitor Cell Mobilization After Percutaneous Angioplasty Procedure
Current Pharmaceutical Design Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Hypertension in Diabetes: Optimal Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Antimicrobial and Biofilm Inhibiting Diketopiperazines
Current Medicinal Chemistry Colorectal Carcinogensis and Suppression of Tumor Development by Inhibition of Enzymes and Molecular Targets
Current Enzyme Inhibition Recent Patents Regarding Essential Oils and the Significance of their Constituents in Human Health and Treatment
Recent Patents on Anti-Infective Drug Discovery Anti-inflammatory Glycosylated Flavonoids as Therapeutic Agents for Treatment of Diabetes-Impaired Wounds
Current Topics in Medicinal Chemistry The Janus Face of Adenosine: Antiarrhythmic and Proarrhythmic Actions
Current Pharmaceutical Design Production and Purification of Functional Lipids Through Enzymatic and Microorganism-Mediated Processes
Current Organic Chemistry Mild Cognitive Impairment: At the Crossroad of Neurodegeneration and Vascular Dysfunction
Current Alzheimer Research A New Risk Chart of Acute Myocardial Infarction in Men by an Innovative Algorithm: A Pilot Study
Current Pharmacogenomics and Personalized Medicine Acute Coronary Syndrome and its Antithrombotic Treatment: Focus on Aspirin and Clopidogrel Resistance
Current Vascular Pharmacology Impact of 13Valent Vaccine for Prevention of Pneumococcal Diseases in Children and Adults at Risk: Possible Scenarios in Campania Region
Infectious Disorders - Drug Targets Lipid Profile Results after Cardiovascular Prevention Programme: Euroaction Model in Spain
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events
Current Drug Targets The Role of PPARs in Obesity and other Insulin Resistance Associated Disorders
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Energy Metabolism in the Normal and in the Diabetic Heart
Current Pharmaceutical Design How Cardiomyocytes Make the Heart Old
Current Pharmaceutical Biotechnology